Clinical Trials Logo

Autosomal Dominant clinical trials

View clinical trials related to Autosomal Dominant.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00771888 Active, not recruiting - Liver Diseases Clinical Trials

Open-Label Extension of LOCKCYST Trial

LOCKCYST-ext
Start date: April 2008
Phase: Phase 2/Phase 3
Study type: Interventional

Positive data originating from two polycystic liver patients treated with somatostatin analogues, showed a volume reduction of 38.3% and 14.9%. These two patients had complicated polycystic livers and no other therapeutic options were available. Patients who participated in LOCKCYST trial are able to benefit from active treatment. Participants will be actively treated for 24 weeks.